CLGM
INBX icon

Capitolis Liquid Global Markets’s Inhibrx INBX Stock Holding History

Capitolis Liquid Global Markets’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Sell
119,200
-5,800
-5% -$581K 0.05% 187
2026
Q1 		$8.4M Buy
+125,000
New +$9.27M 0.05% 199

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capitolis Liquid Global Markets's INBX Position: Q2 2026 in Review

Capitolis Liquid Global Markets reduced its Inhibrx (INBX) stake by 4.6% in Q2 2026, selling an estimated $581K and leaving 119,200 shares worth $11.3M. The position accounts for 0.05% of the portfolio, ranked #187.

Capitolis Liquid Global Markets first reported a position in INBX in Q1 2026 and has held it in 2 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Capitolis Liquid Global Markets held 119,200 shares of Inhibrx worth $11.3M as of Q2 2026.
  • Capitolis Liquid Global Markets sold 5,800 Inhibrx shares in Q2 2026, an estimated $581K.
  • Inhibrx made up 0.05% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #187 holding.
  • Capitolis Liquid Global Markets first reported a position in Inhibrx in Q1 2026 and has held it in 2 quarters since.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.